|Title||Sales & Operations Planning Process Optimization at Novo Nordisk A/S|
|Author||Lionett, Nicklas (Copenhagen University College of Engineering, IHK)
|Institution||Ingeniørhøjskolen i København, IHK, DK-2750 Ballerup, Denmark|
|Thesis level||Bachelor thesis|
|Education||Bachelor of Engineering|
|Abstract||Organizations are continuously attempting to optimize internal processes in the supply chain to reduce costs, and avoid scrap due to possible expirations. One specific process in the supply chain contributing to possible cost reductions is the Sales & Operations Planning process (S&OP). S&OP is a collaborative process that balances the demand- and supply side. An excellent S&OP process will have streamlined all objectives and plans of departmental functions, thus having created the “one number plan”, which is accessible for all.
the purpose of this project was to optimize the current S&OP process at Novo Nordisk A/S, China. This was done through analyzing the current S&OP process on the basis of a theoretic figure provided by T.F Wallace and R.A Stahl. This figure encompasses five phases: Data Gathering, Demand Planning, Supply Planning, Pre-Meeting, and Executive Meeting. Additionally, the current collaboration level among S&OP process participants was evaluated. Subsequently, tailored strategies and methods, according to surfaced issues and challenges in the analysis, were provided as plausible solutions in the project.
The results from the analysis have been based on interviews, observations, and data transcripts. Countermeasures in the form of credible strategies and methods were provided for the current S&OP process. These strategies and methods, tailored to the specific challenge, were workshops and seminars, sales forecasting tools, tools for root cause analysis, and tools for continuous improvement.
Based on a ROI analysis, it was found that the estimated cost of above-mentioned strategies and methods would be a one-time expenditure of approximately 200,000.00DKK and that the estimated benefit would be substantial. As result, it is recommended that Novo Nordisk A/S, China, utilize the suggested strategy plan, as it in future perspectives can prove to be quite profitable almost instantly, if implemented correctly.
|External partner||Ledere og medarbejdere i private virksomheder|
|Admin||Creation date: 2011-12-12 Update date: 2012-11-05 Source: ihk ID: ihk-10462588 Original MXD|